Researchers Examine How Bacteria Become Resistant to Antibiotics

Investigating exactly how bacteria learn to fend off antibiotics prescribed to treat infections is the subject of new research by Assistant Professor Brian G. Miller of FSU’s Department of Chemistry and Biochemistry and one of his graduate research assistants, Kevin K. Desai.

They have found that bacteria are remarkably resilient to toxic substances, such as antibiotics, because bacteria have the innate ability to produce a large variety of proteins. Those proteins then are able to do things such as pump toxins out or alter toxins so that they can no longer kill the bacteria.

“Most of us take antibiotics to eliminate infections without considering what would happen if they failed to work,” said Kevin Desai, a graduate research assistant in Florida State’s Department of Chemistry and Biochemistry. “While treating bacterial infections has typically been as easy as swallowing a pill, researchers are apprehensive about the increasing frequency of infections that are resistant to antibiotics, and are searching for ways to regain the upper hand.”

In their study, Miller and Desai learned that about 2 percent of all the proteins produced by the model bacterium E. coli can be linked to enabling resistance to a single toxin called bromoacetate. Their research also has implications in elucidating the function of specific proteins and understanding how bacteria in the environment can survive in the presence of toxic manmade chemicals such as pesticides.

A paper describing Desai and Miller’s work was published this week in the prestigious journal Proceedings of the National Academy of Sciences. That paper is titled “Recruitment of Genes and Enzymes Conferring Resistance to the Nonnatural Toxin Bromoacetate.”

“The recent rise of antibiotic resistance demonstrates that bacteria are capable of rapidly evolving evasive strategies,” they wrote. “It also has exposed our lack of knowledge about the evolutionary processes leading to resistance.”

Understanding the mechanisms by which bacteria evade environmental threats has direct relevance for understanding and combating the rise of antibiotic resistance, Desai and Miller added.

The techniques described in the paper will be highly useful for other researchers in the field because it will allow them to predict the resistance to specific antibiotics. Any resistance mechanisms identified could then be inhibited so that the antibiotics will retain their effectiveness.

Their research was funded, in part, by grants from the James and Ester King Biomedical Research Program and from the National Institute of Diabetes and Digestive and Kidney Diseases.

CONTACT: Kevin K. Desai
(850) 645-8683; kkd02d@fsu.edu
or Brian G. Miller
(850) 645-6570; miller@chem.fsu.edu

Media Contact

Kevin K. Desai Newswise Science News

More Information:

http://www.fsu.edu

All latest news from the category: Studies and Analyses

innovations-report maintains a wealth of in-depth studies and analyses from a variety of subject areas including business and finance, medicine and pharmacology, ecology and the environment, energy, communications and media, transportation, work, family and leisure.

Back to home

Comments (0)

Write a comment

Newest articles

Distance learning can improve women’s access to vocational training as animal health care practitioners in Nepal. Image Credit: Heifer International

Hybrid Job Training Boosts Women’s Participation in Nepal

Globally, women’s workforce participation is about 25% lower than men’s, often due to barriers such as domestic responsibilities and cultural norms. Vocational training can increase employment opportunities, but women may…

CO2release increase under repeated drying-rewetting cycles (DWCs). Image Credit: Suzuki, Nagano et al., 2025 SOIL

Drying and Rewetting Cycles Boost Soil CO2 Emissions

Niigata, Japan – The amount of carbon dioxide (CO2) released by microbial decomposition of soil organic carbon on a global scale is approximately five times greater than the amount of…

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers. Oregon State's Olena Taratula and collaborators including OSU postdoctoral researcher Babak Mamnoon and Maureen Baldwin, a physician at Oregon Health & Science University, designed a type of drug nanocarrier known as a polymersome to specifically target a protein in choriocarcinoma cells. Depicted is a polymersome with its methotrexate cargo. Illustration by Parinaz Ghanbari. Image Credit: Parinaz Ghanbari

Improved Treatment Method for Rare Pregnancy-Related Cancer

PORTLAND, Ore. – A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other…